We present the advantages of using robust health equity research methods and introduce specialized machine learning database tools
Listen in to this recorded webinar as our experts discuss best practices for inclusive language in life sciences research and communications.
Learn how to create a strategic plan to support evidence generation for reimbursement and to increase patient access to orphan drugs.
Understand the opportunities and challenges in generating and communicating evidence for COVID-19 treatments and vaccines.
A Market Access Evidence Roadmap can help identify areas of evidence generation required to support reimbursement and increase access to your product.
This webinar, based on PRO labeling of cancer treatment drugs, examines trends in EMA and FDA labeling based on patient-reported outcomes (PROs).
Watch this webinar where our experts discuss different approaches for developing rigorous economic model structures for rare diseases.
For this advanced session on network meta-analysis, listen as our panel of experts discusses some of the recent developments in Bayesian NMA.
Watch this introductory presentation as our experts walk through an overview of this approach used to help asses relative differences in treatments.
In this webinar, we will share design strategies for avoiding selection bias and improving efficiency in observational studies.
This webinar will guide you through the basics of creating effective GVDs using proven strategies for reflecting your product’s value.
Our panel of experts discuss the challenges of collecting, analyzing, and interpreting PRO data in oncology clinical trials.
Causal Inference Methods for Real-World Evidence
Please join Xabier Garcia de Albeniz for this recorded 30-minute workshop